1. Home
  2. NBTB vs OGN Comparison

NBTB vs OGN Comparison

Compare NBTB & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NBTB

NBT Bancorp Inc.

HOLD

Current Price

$41.88

Market Cap

2.3B

Sector

Finance

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$7.12

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBTB
OGN
Founded
1856
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.7B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NBTB
OGN
Price
$41.88
$7.12
Analyst Decision
Buy
Hold
Analyst Count
3
4
Target Price
$52.33
$15.75
AVG Volume (30 Days)
208.6K
5.9M
Earning Date
10-27-2025
11-10-2025
Dividend Yield
3.53%
1.12%
EPS Growth
5.89
N/A
EPS
3.02
1.91
Revenue
$629,728,000.00
$6,301,000,000.00
Revenue This Year
$27.08
N/A
Revenue Next Year
$9.17
N/A
P/E Ratio
$13.89
$3.73
Revenue Growth
16.88
N/A
52 Week Low
$37.31
$6.18
52 Week High
$52.44
$17.23

Technical Indicators

Market Signals
Indicator
NBTB
OGN
Relative Strength Index (RSI) 55.23 40.52
Support Level $40.80 $6.95
Resistance Level $42.58 $7.86
Average True Range (ATR) 0.97 0.31
MACD 0.12 0.04
Stochastic Oscillator 71.45 18.68

Price Performance

Historical Comparison
NBTB
OGN

About NBTB NBT Bancorp Inc.

NBT Bancorp Inc is a financial holding company that operates through its subsidiaries. The company's principal sources of revenue include management fees and dividends it receives through its subsidiaries. Its business, predominantly conducted through NBT Bank, consists of providing commercial banking, retail banking, and wealth management services to customers in its market area, which includes upstate New York, northeastern Pennsylvania, southern New Hampshire, western Massachusetts, Vermont, southern Maine, and central and northwestern Connecticut. The company's reportable segments are Banking and Retirement Plan Administration. A majority of its revenue is generated from the Banking segment.

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Share on Social Networks: